1 |
American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer, Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2009;19:1167-1214
DOI
|
2 |
Schirrmeister H, Buck A, Guhlmann A, Reske SN. Anatomical distribution and sclerotic activity of bone metastases from thyroid cancer assessed with F-18 sodium fluoride positron emission tomography. Thyroid 2001;11:677-683
DOI
|
3 |
Ota N, Kato K, Iwano S, Ito S, Abe S, Fujita N, et al. Comparison of -fluoride PET/CT, -FDG PET/CT and bone scintigraphy (planar and SPECT) in detection of bone metastases of differentiated thyroid cancer: a pilot study. Br J Radiol 2014;87:20130444
DOI
|
4 |
Lee SJ, Lee WW, Kim SE. Bone positron emission tomography with or without CT is more accurate than bone scan for detection of bone metastasis. Korean J Radiol 2013;14:510-519
DOI
|
5 |
Wolff H, Breda DJ, Da Silva N, Hartmann AA. False-positive I-131 deposition in a parotid gland duct ectasia. Clin Nucl Med 1998;23:257-259
DOI
|
6 |
Agriantonis DJ, Hall L, Wilson MA. Pitfalls of I-131 whole body scan interpretation: bronchogenic cyst and mucinous cystadenoma. Clin Nucl Med 2008;33:325-327
DOI
|
7 |
Buton L, Morel O, Gault P, Illouz F, Rodien P, Rohmer V. Falsepositive iodine-131 whole-body scan findings in patients with differentiated thyroid carcinoma: report of 11 cases and review of the literature. Ann Endocrinol (Paris) 2013;74:221-230
DOI
|
8 |
Oh JR, Byun BH, Hong SP, Chong A, Kim J, Yoo SW, et al. Comparison of whole-body imaging, SPECT/CT, and -FDG PET/CT in the detection of metastatic thyroid cancer. Eur J Nucl Med Mol Imaging 2011;38:1459-1468
DOI
|
9 |
Grant FD, Fahey FH, Packard AB, Davis RT, Alavi A, Treves ST. Skeletal PET with 18F-fluoride: applying new technology to an old tracer. J Nucl Med 2008;49:68-78
|
10 |
Schlumberger M, Tubiana M, De Vathaire F, Hill C, Gardet P, Travagli JP, et al. Long-term results of treatment of 283 patients with lung and bone metastases from differentiated thyroid carcinoma. J Clin Endocrinol Metab 1986;63:960-967
DOI
|
11 |
Brown AP, Greening WP, McCready VR, Shaw HJ, Harmer CL. Radioiodine treatment of metastatic thyroid carcinoma: the Royal Marsden Hospital experience. Br J Radiol 1984;57:323-327
DOI
|
12 |
Durante C, Haddy N, Baudin E, Leboulleux S, Hartl D, Travagli JP, et al. Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy. J Clin Endocrinol Metab 2006;91:2892-2899
DOI
|
13 |
Davila D, Antoniou A, Chaudhry MA. Evaluation of osseous metastasis in bone scintigraphy. Semin Nucl Med 2015;45:3-15
DOI
|
14 |
Ito S, Kato K, Ikeda M, Iwano S, Makino N, Tadokoro M, et al. Comparison of 18F-FDG PET and bone scintigraphy in detection of bone metastases of thyroid cancer. J Nucl Med 2007;48:889-895
DOI
|
15 |
Qiu ZL, Xue YL, Song HJ, Luo QY. Comparison of the diagnostic and prognostic values of 99mTc-MDP-planar bone scintigraphy, 131I-SPECT/CT and 18F-FDG-PET/CT for the detection of bone metastases from differentiated thyroid cancer. Nucl Med Commun 2012;33:1232-1242
DOI
|
16 |
Kang JY, Lee WW, So Y, Lee BC, Kim SE. Clinical Usefulness of (18)F-fluoride Bone PET. Nucl Med Mol Imaging 2010;44:55-61
DOI
|
17 |
Yoon SH, Kim KS, Kang SY, Song HS, Jo KS, Choi BH, et al. Usefulness of (18)F-fluoride PET/CT in Breast Cancer Patients with Osteosclerotic Bone Metastases. Nucl Med Mol Imaging 2013;47:27-35
DOI
|
18 |
Sampson E, Brierley JD, Le LW, Rotstein L, Tsang RW. Clinical management and outcome of papillary and follicular (differentiated) thyroid cancer presenting with distant metastasis at diagnosis. Cancer 2007;110:1451-1456
DOI
|